462510 — Lameditech Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Lameditech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts
Standards:	KAS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,029	2,056	2,918	6,577	7,187
Cost of Revenue
Gross Profit	367	285	899	2,357	3,148
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	2,910	5,400	6,444	16,239	19,002
Operating Profit	-1,881	-3,344	-3,526	-9,662	-11,815
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-1,867	-4,430	-8,305	-9,484	-11,367
Provision for Income Taxes
Net Income After Taxes	-1,867	-4,430	-8,305	-9,484	-11,367
Net Income Before Extraordinary Items
Net Income	-1,867	-4,430	-8,305	-9,484	-11,367
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-1,867	-4,430	-8,305	-9,484	-11,367
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-216	-512	-960	-1,177	-1,302
Dividends per Share